UNITED STATES SECURITIES AND EXCHANGE COMMISSION SECURITIES EXCHANGE ACT OF 1934 RELEASE NO. 40130 / June 25, 1998 ADMINISTRATIVE PROCEEDING File No. 3-9634 ORDER INSTITUTING CEASE-AND-DESIST PROCEEDINGS PURSUANT TO SECTION 21C OF THE SECURITIES EXCHANGE ACT OF 1934 FOR ALLEGED VIOLATIONS OF THE COMMISSION S TENDER OFFER RULES The Commission announced today that it instituted administrative cease-and- desist proceedings against WHX Corporation ( WHX ), a Delaware corporation with its principal place of business in New York City. The Order Instituting Public Cease-and-Desist Proceedings ("Order") alleges that WHX violated the Commission s tender offer rules in connection with its tender offer for Dynamics Corporation of America ( DCA ) commenced on March 31, 1997. The Order alleges that in its initial form, the tender offer violated the All Holders Rule (Rule 14d-10(a)(1) under the Securities Exchange Act of 1934 ( Exchange Act )), in that it excluded shareholders who were not record holders of DCA shares or who could not otherwise deliver a valid proxy along with their shares. In April 1997, after WHX s counsel was advised that the Commisison had authorized an emergency enforcement action to enjoin the offer, WHX amended the offer to open it to all shareholders. The Order further alleges that thereafter, WHX violated Rules 14d-4(c) and 14d-6(d) under the Exchange Act when, upon expiration of the offer, it waived conditions that had not been satisfied and, without extending the offer to inform shareholders of that material change, proceeded immediately to buy the shares that had been tendered. Among the express conditions that WHX placed on its offer were the following: (1) the redemption, invalidation, or inapplicability to the offer of DCA s poison pill anti- takeover provision; (2) the inapplicability of New York s anti-takeover statute to the acquisition of shares pursuant to the offer or merger; and (3) the absence of a competing friendly offer for DCA. As of June 13, the expiration date, WHX had been unsuccessful in its efforts in court to invalidate the poison pill and obtain relief from New York s anti-takeover statute. Also as of that date, there was a competing friendly merger agreement that DCA had entered into with another company. The Order alleges that WHX s waiver of these conditions on June 13 was a material change that required WHX to extend its offer for a minimum of five business days to inform DCA s shareholders of the change through the dissemination of additional tender offer materials. WHX, however, did not extend its offer, and the only disclosure it provided to DCA shareholders came in the form of a press release issued three days after it closed the offer. The Order alleges that by failing to extend the offer after waiving the conditions, WHX deprived DCA shareholders who had tendered their shares of the opportunity to withdraw them. ======END OF PAGE 1====== Finally, the Order alleges that since the market price of DCA shares was higher than WHX s tender price during what should have been the five-day extension period, economically rational shareholders would have withdrawn their shares had WHX extended its offer. WHX, therefore, was unjustly enriched by the difference between what it paid for the shares and what it would have had to pay for them had it extended the offer. The Order institutes public proceedings to determine whether the Commission should enter an order requiring (a) WHX to cease-and-desist from committing or causing any violation and any future violation of Rules 14d-4(c),14d- 6(d) and 14d-10(a)(1) of the Exchange Act and (b) WHX to pay disgorgement pursuant to Section 21C of the Exchange Act. A hearing will be held to determine whether the staff s allegations are true and to provide the respondents with an opportunity to respond to the charges. ======END OF PAGE 2======